ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,511,000 | -54.7% | 161,076 | -35.4% | 0.15% | -43.1% |
| Q2 2015 | $14,360,000 | -35.3% | 249,529 | -28.4% | 0.27% | -27.2% |
| Q1 2015 | $22,195,000 | +109.6% | 348,598 | +103.2% | 0.37% | +125.2% |
| Q4 2014 | $10,590,000 | -48.0% | 171,531 | -67.3% | 0.16% | -40.5% |
| Q3 2014 | $20,357,000 | -28.8% | 524,247 | -36.8% | 0.27% | -17.5% |
| Q2 2014 | $28,583,000 | -23.7% | 829,698 | -4.3% | 0.33% | -22.6% |
| Q1 2014 | $37,474,000 | – | 867,252 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,976,526 | $368,991,000 | 11.95% |
| HWG Holdings LP | 155,584 | $9,606,000 | 6.84% |
| DOWLING & YAHNKE LLC | 676,313 | $41,756,000 | 5.20% |
| Ghost Tree Capital, LLC | 150,000 | $9,261,000 | 4.44% |
| WILLIAM HARRIS INVESTORS INC | 276,870 | $17,094,000 | 4.41% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 61,225 | $3,780,000 | 2.87% |
| Opus Point Partners Management, LLC | 45,418 | $2,804,000 | 2.77% |
| PINNACLE ASSOCIATES LTD | 1,917,838 | $118,407,000 | 2.32% |
| Ghost Tree Capital, LLC | 50,000 | $3,087,000 | 1.48% |
| Adamant Biomedical Investments AG | 100,000 | $6,174,000 | 1.48% |